Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.
PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.
The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.
New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.
Two PNNL interns are behind recent innovation in real-time testing and continuous monitoring for pH and the concentration of chemicals of interest in chemical solutions; outcomes have applicability not only to nuclear, but to industries.
Risk analysis on the plutonium-fueled power system that supplies electricity to the Mars rover answered the “what if” nuclear safety questions for NASA.
On the looming 10th anniversary of the Fukushima disaster at the Daiichi Power Station in Japan, PNNL looks back at the science and solidarity it has shared with Fukushima and its nuclear cleanup effort.
